Expression analysis of endoglin missense and truncation mutations: Insights into protein structure and disease mechanisms

Human Molecular Genetics

Volumn 9, Issue 5, 2000, Pages 745-755

  Lux, Andreas ^a   Gallione, Carol J ^a   Marchuk, Douglas A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; MUTANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; GENE EXPRESSION; GENE MUTATION; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN LOCALIZATION; RENDU OSLER WEBER DISEASE; STOP CODON;

ANIMALIA;

EID: 0034701244     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.5.745     Document Type: Article

References (39)

1. Plauchu, H. and Bideau, H. (1984) Epidemiologie et constitution d'un registre de population a propos d'une concentration geographique d'une maladie hereditaire rare. Population, 4-5, 765-786.
2. Vase, P. and Grove, O. (1986) Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology, 91, 1079-1083.
3. Porteous, M.E., Bum, J. and Proctor, S.J. (1992) Hereditary haemorrhagic telangieclasia: a clinical analysis, J. Med. Genet., 29, 527-530.
4. Jessurun, G.A., Kamphuis, D.J., van der Zande, F.H. and Nossent, J.C. (1993) Cerebral arteriovenous malformations in the Netherlands Antilles. High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin. Neurol. Neurosurg., 95, 193-198.
5. Guttmacher, A.E., McKinnon, W.C. and Upton, M.D. (1994) Hereditary hemorrhagic telangiectasia: a disorder in search of the genetics community [letter]. Am. J. Med. Genet., 52, 252-253.
6. Mandzia, J.L., ter Brugge, K.G., Faughnan, M.E. and Hyland, R.H. (1999) Spinal cord arteriovenous malformations in two patients with hereditary hemorrhagic telangiectasia. Childs Nerv. Syst., 15, 80-83.
7. Haitjema, T., Westermann, C.J., Overtoom, T.T., Timmer, R., Disch, F., Mauser, H. and Lammers, J.W. (1996) Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch. Intern. Med., 156, 714-719.
8. McAllister, K.A., Grogg, K.M., Johnson, D.W., Gallione, C.J., Baldwin, M.A., Jackson, C.E., Helmbold, E.A., Markel, D.S., McKinnon, W.C., Murrell, J. et al. (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genet., 8, 345-351.
9. McAllister, K.A., Baldwin, M.A., Thukkani, A.K., Gallione, C.J., Berg, J.N., Porteous, M.E., Guttmacher, A.E. and Marchuk, D.A. (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum. Mol. Genet., 4, 1983-1985.
10. Johnson, D.W., Berg, J.N., Baldwin, M.A., Gallione, C.J., Marondel, I., Yoon, S.J., Stenzel, T.T., Speer, M., Pericak-Vance, M.A., Diamond, A. et al. (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nature Genet., 13, 189-195.
11. Berg, J.N., Gallione, C.J., Stenzel, T.T., Johnson, D.W., Allen, W.P., Schwartz, C.E., Jackson, C.E., Porteous, M.E. and Marchuk, D.A. (1997) The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am. J. Hum. Genet., 61, 60-67.
12. Shovlin, C.L., Hughes, J.M., Scott, J., Seidman, C.E. and Seidman, J.G. (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am. J. Hum. Genet., 61, 68-79.
13. Lux, A., Attisano, L. and Marchuk, D.A. (1999) Assignment of transforming growth factor β1 and β3 and a third new ligand to the type I receptor ALK-1. J. Biol. Chem., 274, 9984-9992.
14. Gougos, A. and Letarte, M. (1988) Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J. Immunol., 141, 1925-1933.
15. Gougos, A. and Letarte, M. (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem., 265, 8361-8364.
16. Gougos, A., St Jacques, S., Greaves, A., O'Connell, P.J., d'Apice, A.J., Buhring, H.J., Bernabeu, C., van Mourik, J.A. and Letarte, M. (1992) Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int. Immol., 4, 83-92.
17. Lastres, P., Bellon, T., Cabanas, C., Sanchez-Madrid, F., Acevedo, A., Gougos, A., Letarte, M. and Bernabeu, C. (1992) Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur. J. Immunol., 22, 393-397.
18. Lastres, P., Letamendia, A., Zhang, H., Rius, C., Almendro, N., Raab, U., Lopez, L.A., Langa, C., Fabra, A., Letarte, M. and Bernabeu, C. (1996) Endoglin modulates cellular responses to TGF-β1. J. Cell Biol., 133, 1109-1121.
19. Cheifetz, S., Bellon, T., Cales, C., Vera, S., Bernabeu, C, Massague, J. and Letarte, M. (1992) Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem., 267, 19027-19030.
20. Zhang, H., Shaw, A.R., Mak, A. and Letarte, M. (1996) Endoglin is a component of the transforming growth factor (TGF)-β receptor complex of human pre-B leukemic cells. J. Immunol., 156, 564-573.
21. Pece-Barbara, N., Cymerman, U., Vera, S., Marchuk, D.A. and Letarte, M. (1999) Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum. Mol. Genet., 8, 2171-2181.
22. Letamendia, A., Lastres, P., Botella, L.M., Raab, U., Langa, C., Velasco, B., Attisano, L. and Bernabeu, C. (1998) Role of endoglin in cellular responses to transforming growth factor-β. A comparative study with betaglycan. J. Biol. Chem., 273, 33011-33019.
23. Yamaguchi, H., Azuma, H., Shigekiyo, T., Inoue, H. and Saito, S. (1997) A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia. Thromb. Haemostasis, 77, 243-247.
24. Gallione, C.J., Klaus, D.J., Yeh, E.Y., Stenzel, T.T., Xue, Y., Anthony, K.B., McAllister, K.A., Baldwin, M.A., Berg, J.N., Lux, A. et al. (1998) Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum. Mutat., 11, 286-294.
25. Pece, N., Vera, S., Cymerman, L., White Jr, R.I., Wrana, J.L. and Letarte, M. (1997) Mutant endoglin in hereditary hemorrhagic telangiectasia type I is transiently expressed intracellularly and is not a dominant-negative. J. Clin. Invest., 100, 2568-2579.
26. Klaus, D.J., Gallione, C.J., Anthony, K., Yen, E.Y., Yu, J., Lux, A., Johnson, D.W. and Marchuk, D.A. (1998) Novel missense and frameshift mutations in the activin receptor-like kinase-1 in HHT. Human Mutation: Online Mutations in Brief, No. 164 (http:/humu.edoc.com/1059-7794/html/ mutation.klautext.htm).
27. Wilkie, A.O. (1994) The molecular basis of genetic dominance. J. Med. Genet., 31, 89-98.
28. Pichuantes, S., Vera, S., Bourdeau, A., Pece, N., Kumar, S., Wayner, E.A. and Letarte, M. (1997) Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens, 50, 265-276.
29. Aridor, M. and Balch, W.E. (1999) Integration of endoplasmic reticulum signaling in health and disease. Nature Med., 5, 745-751.
30. Brockhausen, I., Schutzbach, J. and Kuhns, W. (1998) Glycoproteins and their relationship to human disease. Acta Anat., 161, 36-78.
31. Hammond, C. and Helenius, A. (1994) Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus. J. Cell Biol., 126, 41-52.
32. Hammond, C. and Helenius, A. (1995) Quality control in the secretory pathway. Curr. Opin. Cell Biol., 7, 523-529.
33. Kukuruzinska, M.A. and Lennon, K. (1998) Protein N-glycosylation: molecular genetics and functional significance. Crit. Rev. Oral Biol. Med., 9, 415-448.
34. Wang, C., Eufemi, M., Turano, C. and Giartosio, A. (1996) Influence of the carbohydrate moiety on the stability of glycoproteins. Biochemistry, 35, 7299-7307.
35. Raab, U., Velasco, B., Lastres, P., Letamendia, A., Cales, C., Langa, C., Tapia, E., Lopez-Bote, J.P., Paez, E. and Bernabeu, C. (1999) Expression of normal and truncated forms of human endoglin. Biochem. J., 339, 579-588.
36. Muth, T.R., Ahn, J. and Caplan, M.J. (1998) Identification of sorting determinants in the C-terminal cytoplasmic tails of the γ-aminobutyric acid transporters GAT-2 and GAT-3. J. Biol. Chem., 273, 25616-25627.
37. Fanning, A.S. and Anderson, J.M. (1998) PDZ domains and the formation of protein networks at the plasma membrane. Curr. Top. Microbiol. Immunol., 228, 209-233.
38. + channels by interaction with a family of membrane-associated guanylate kinases. Nature, 378, 85-88.
39. Kornau, H.C., Schenker, L.T., Kennedy, M.B. and Seeburg, P.H. (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science, 269, 1737-1740.